Jennifer May
Surgical · East Amherst, NYNPI 1043296338
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.8% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 24.4% of the total. Among surgical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 316 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$923
- Sun Pharmaceutical Industries Inc.$497
- UCB, Inc.$376
- Sanofi$274
- Regeneron Healthcare Solutions, Inc.$258
- plus $2K from 16 others
What the payments were for
- Food & beverage$4,66191%
- Education$4749%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 83 | $1,253 |
| Novartis | 88 | $923 |
| Sun Pharmaceutical Industries Inc. | 24 | $497 |
| UCB, Inc. | 22 | $376 |
| Sanofi | 11 | $274 |
| Regeneron Healthcare Solutions, Inc. | 8 | $258 |
| Johnson & Johnson | 5 | $235 |
| Pfizer | 10 | $228 |
| Lilly USA, LLC | 12 | $218 |
| Dermavant Sciences, Inc. | 18 | $204 |
| Incyte Corporation | 3 | $148 |
| Galderma Laboratories, L.p. | 6 | $99 |
| E.r. Squibb & Sons, L.L.C. | 6 | $95 |
| LEO Pharma Inc. | 4 | $68 |
| VYNE Pharmaceuticals Inc. | 3 | $56 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $46 |
| Nabriva Therapeutics, PLC | 2 | $39 |
| Boehringer Ingelheim | 2 | $38 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| Biofrontera Inc. | 1 | $18 |
| Botanix SB Inc | 1 | $16 |
| Organon | 2 | $13 |
How this compares
$5,135 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 58 | $214,003 |
| Humira PenAdalimumab | 13 | $90,734 |
| Halobetasol Propionate | 143 | $8,061 |
| Clobetasol Propionate | 118 | $4,670 |
| Fluocinonide | 17 | $2,729 |
| Metronidazole | 28 | $1,741 |
| Ketoconazole | 54 | $1,405 |
| Clindamycin Phosphate | 50 | $1,389 |
| Tretinoin | 15 | $1,310 |
| Fluorouracil | 20 | $1,044 |
| Triamcinolone Acetonide | 68 | $794 |
| Spironolactone | 48 | $649 |
| Minocycline Hcl | 22 | $520 |
| Doxycycline Monohydrate | 19 | $439 |
| Hydroxyzine Hcl | 19 | $342 |
Paid to pharmacies, not to this prescriber.
Other surgical in East Amherst
- Lindsay SchweikarthAlbany$324K
- Nicole FeinNew York$225K
- Kenneth RuizNew York$93K
- Terry LinNew York$70K
- Beth PhillipsEast Syracuse$51K
- James DoolittleNew York$46K
- Tanya GeistAmherst$43K
- Irina KommNew York$39K
- Sarah MartineckWilliamsville$34K
- Richard DalabaAlbany$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.